Dallah Healthcare Company (4004.SR) SAU
Currency In SAR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.58B |
| Enterprise Value | 14.3B |
| P/E Ratio | 9.12 |
| PEG Ratio | 0.42 |
| Price/Sales Ratio | 1.68 |
| Price/Book Ratio | 1.62 |
| Enterprise/Revenue | 2.58 |
| Enterprise/EBITDA | 10.65 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.19 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.18 |
Income Statement
| Revenue | 4.07B |
| Revenue/Share | 35.42 |
| Gross Profit | 1.42B |
| EBITDA | 783.5M |
| Net Income | 538M |
| Diluted EPS | 5.32 |
Balance Sheet
| Total Cash | 95.74M |
| Total Cash/Share | 0.79 |
| Total Debt | 3.97B |
| Total Debt/Equity | 0.88 |
| Current Ratio | 1.56 |
| Book Value Per Share | 37.12 |
Price History
| 52-Week Change | -51.21 |
| 52-Week High | 124.92 |
| 52-Week Low | 55.1 |
| Moving Average 50 Days | 72.45 |
| Moving Average 200 Days | 88.51 |
Statistics
| Average Volume | 166,075 |
| Shares Outstanding | 120.96M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.75 |
| Trailing Annual Dividend Yield | 2.92 |
| Payout Ratio | 0.27 |
| Last Split Factor | 6:5 |
| Last Split Date | August 31, 2026 |
AD
